Clindamycin Hydrochloride Capsule
Product Images NDC 51655-710

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clindamycin Hydrochloride (NDC 51655-710). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51655-710-52 (51655 710 52 Rev A 02 23)

51655-710-52 (51655 710 52   Rev A 02 23)
Clindamycin Hydrochloride Capsules, USP 150 mg, 30 count prescription bottle label. The label includes storage instructions, manufacturer details by Northwind Pharmaceuticals in Indianapolis, IN, and repackaging information from Micro Labs USA Inc. It specifies to see package insert for dosage and cautions to keep out of reach of children.*
FDA Label Image

Clindamycinhcl-str.jpg (Clindamycinhcl Str)

Clindamycinhcl-str.jpg (Clindamycinhcl Str)
Chemical structure of clindamycin hydrochloride, depicting the molecular arrangement of atoms and bonds including functional groups characteristic of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.